Vivanza Biosciences Profit & Loss Annual

BSE: 530057 | NSE: - | ISIN: INE984E01035 | Sector: Biotechnology & Drugs
2.10 -0.02 (-0.94%)Updated : 08 Jul 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Total Operating Expense 7.8026.7817.1510.49
Other Net 0.060.050.480.83
Diluted Weighted Average Shares 4.003.914.004.00
Depreciation/ Amortization 0.010.010.000.01
Operating Income -0.381.050.66-0.09
Net Income -0.670.550.600.33
Income Availableto Com Excl Extra Ord -0.670.550.600.33
Net Income Before Taxes -0.670.700.720.33
Other Operating Expenses Total 0.390.370.290.53
Net Income After Taxes -0.670.550.600.33
Income Availableto Com Incl Extra Ord -0.670.550.600.33
Costof Revenue Total 6.8225.9516.519.65
Gross Profit 0.601.881.300.75
Interest Inc( Exp) Net- Non- Op Total -0.35-0.41-0.42-0.41
Diluted Net Income -0.670.550.600.33
Provisionfor Income Taxes 0.010.150.120.00
period Type ----
Net Income Before Extra Items -0.670.550.600.33
Total Revenue 7.4227.8417.8110.40
period Length 12.0012.0012.0012.00
Revenue 7.4227.8417.8110.40
Selling/ General/ Admin Expenses Total 0.580.450.350.30
Diluted Normalized EPS -0.170.140.150.08
Diluted EPS Excluding Extra Ord Items -0.170.140.150.08
Total Adjustmentsto Net Income --0.00-
Unusual Expense( Income) --0.000.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,209.65+62.65(2.92%)
1,440.90+5.35(0.37%)
3,478.05-188.80 (-5.15%)